[Data],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lane,Sample_ID,Sample_Name,GenomeFolder,Index,bait_name,default_library_type,default_tag_sequence,default_tagtwo_sequence,email_addresses,email_addresses_of_followers,email_addresses_of_managers,email_addresses_of_owners,gbs_plex_name,is_control,is_pool,lane_id,lane_priority,library_name,organism,organism_taxon_id,project_cost_code,project_id,project_name,purpose,qc_state,request_id,required_insert_size_range,sample_accession_number,sample_cohort,sample_common_name,sample_consent_withdrawn,sample_control_type,sample_description,sample_donor_id,sample_id,sample_is_control,sample_name,sample_public_name,sample_reference_genome,sample_supplier_name,spiked_phix_tag_index,study_accession_number,study_alignments_in_bam,study_contains_nonconsented_human,study_contains_nonconsented_xahuman,study_description,study_id,study_name,study_reference_genome,study_separate_y_chromosome_data,study_title,tag_index,
1,3486458,EGAN00001013185,,,,No PCR,,,cdt@sanger.ac.uk cs4@sanger.ac.uk las@sanger.ac.uk lm5@sanger.ac.uk ly2@sanger.ac.uk sm2@sanger.ac.uk som@sanger.ac.uk,las@sanger.ac.uk ly2@sanger.ac.uk som@sanger.ac.uk,cdt@sanger.ac.uk cs4@sanger.ac.uk lm5@sanger.ac.uk sm2@sanger.ac.uk,,,0,0,3792852,0,PD4252b_wg 3486458,,9606,S0799,696,CGP Stimulous grant,standard,pass,3642672,from:300 to:500,EGAN00001013185,,Homo sapiens,,,,,1257833,,PD4252b_wg,PD4252b,,,168,EGAS00001000902,1,0,0,We propose to definitively characterise the somatic genetics of Metastatic breast cancer through generation of comprehensive catalogues of somatic mutations in Metastatic breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses. ,2040,Metastatic Breast Cancer Whole Genome,Homo_sapiens (CGP_GRCh37.NCBI.allchr_MT),,Metastatic Breast Cancer Whole Genome,,
2,3486458,EGAN00001013185,,,,No PCR,,,cdt@sanger.ac.uk cs4@sanger.ac.uk las@sanger.ac.uk lm5@sanger.ac.uk ly2@sanger.ac.uk sm2@sanger.ac.uk som@sanger.ac.uk,las@sanger.ac.uk ly2@sanger.ac.uk som@sanger.ac.uk,cdt@sanger.ac.uk cs4@sanger.ac.uk lm5@sanger.ac.uk sm2@sanger.ac.uk,,,0,0,3792853,0,PD4252b_wg 3486458,,9606,S0799,696,CGP Stimulous grant,standard,pass,3642673,from:300 to:500,EGAN00001013185,,Homo sapiens,,,,,1257833,,PD4252b_wg,PD4252b,,,168,EGAS00001000902,1,0,0,We propose to definitively characterise the somatic genetics of Metastatic breast cancer through generation of comprehensive catalogues of somatic mutations in Metastatic breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses. ,2040,Metastatic Breast Cancer Whole Genome,Homo_sapiens (CGP_GRCh37.NCBI.allchr_MT),,Metastatic Breast Cancer Whole Genome,,
3,3486458,EGAN00001013185,,,,No PCR,,,cdt@sanger.ac.uk cs4@sanger.ac.uk las@sanger.ac.uk lm5@sanger.ac.uk ly2@sanger.ac.uk sm2@sanger.ac.uk som@sanger.ac.uk,las@sanger.ac.uk ly2@sanger.ac.uk som@sanger.ac.uk,cdt@sanger.ac.uk cs4@sanger.ac.uk lm5@sanger.ac.uk sm2@sanger.ac.uk,,,0,0,3792854,0,PD4252b_wg 3486458,,9606,S0799,696,CGP Stimulous grant,standard,pass,3642674,from:300 to:500,EGAN00001013185,,Homo sapiens,,,,,1257833,,PD4252b_wg,PD4252b,,,168,EGAS00001000902,1,0,0,We propose to definitively characterise the somatic genetics of Metastatic breast cancer through generation of comprehensive catalogues of somatic mutations in Metastatic breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses. ,2040,Metastatic Breast Cancer Whole Genome,Homo_sapiens (CGP_GRCh37.NCBI.allchr_MT),,Metastatic Breast Cancer Whole Genome,,
4,3486464,EGAN00001016547,,,,No PCR,,,cdt@sanger.ac.uk cs4@sanger.ac.uk las@sanger.ac.uk lm5@sanger.ac.uk ly2@sanger.ac.uk sm2@sanger.ac.uk som@sanger.ac.uk,las@sanger.ac.uk ly2@sanger.ac.uk som@sanger.ac.uk,cdt@sanger.ac.uk cs4@sanger.ac.uk lm5@sanger.ac.uk sm2@sanger.ac.uk,,,0,0,3792855,0,PD4243b_wg 3486464,,9606,S0799,696,CGP Stimulous grant,standard,pass,3642675,from:300 to:500,EGAN00001016547,,Homo sapiens,,,,,1261500,,PD4243b_wg,PD4243b,,,168,EGAS00001000902,1,0,0,We propose to definitively characterise the somatic genetics of Metastatic breast cancer through generation of comprehensive catalogues of somatic mutations in Metastatic breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses. ,2040,Metastatic Breast Cancer Whole Genome,Homo_sapiens (CGP_GRCh37.NCBI.allchr_MT),,Metastatic Breast Cancer Whole Genome,,
5,3486464,EGAN00001016547,,,,No PCR,,,cdt@sanger.ac.uk cs4@sanger.ac.uk las@sanger.ac.uk lm5@sanger.ac.uk ly2@sanger.ac.uk sm2@sanger.ac.uk som@sanger.ac.uk,las@sanger.ac.uk ly2@sanger.ac.uk som@sanger.ac.uk,cdt@sanger.ac.uk cs4@sanger.ac.uk lm5@sanger.ac.uk sm2@sanger.ac.uk,,,0,0,3792856,0,PD4243b_wg 3486464,,9606,S0799,696,CGP Stimulous grant,standard,pass,3642676,from:300 to:500,EGAN00001016547,,Homo sapiens,,,,,1261500,,PD4243b_wg,PD4243b,,,168,EGAS00001000902,1,0,0,We propose to definitively characterise the somatic genetics of Metastatic breast cancer through generation of comprehensive catalogues of somatic mutations in Metastatic breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses. ,2040,Metastatic Breast Cancer Whole Genome,Homo_sapiens (CGP_GRCh37.NCBI.allchr_MT),,Metastatic Breast Cancer Whole Genome,,
6,3660662,EGAN00001007929,,CGATGTTT,,Standard,CGATGTTT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086115 3660662,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007929,,Homo sapiens,,,,,1108121,,UK10K_ALS5086115,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,2,
6,3660663,EGAN00001007930,,TTAGGCAT,,Standard,TTAGGCAT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086116 3660663,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007930,,Homo sapiens,,,,,1108123,,UK10K_ALS5086116,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,3,
6,3660664,EGAN00001007931,,TGACCACT,,Standard,TGACCACT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086117 3660664,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007931,,Homo sapiens,,,,,1108125,,UK10K_ALS5086117,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,4,
6,3660665,EGAN00001007932,,ACAGTGGT,,Standard,ACAGTGGT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086118 3660665,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007932,,Homo sapiens,,,,,1108127,,UK10K_ALS5086118,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,5,
6,3660666,EGAN00001007933,,GCCAATGT,,Standard,GCCAATGT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086119 3660666,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007933,,Homo sapiens,,,,,1108129,,UK10K_ALS5086119,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,6,
6,3660667,EGAN00001007934,,CAGATCTG,,Standard,CAGATCTG,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086120 3660667,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007934,,Homo sapiens,,,,,1108131,,UK10K_ALS5086120,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,7,
6,3660661,EGAN00001007935,,ACTTGATG,,Standard,ACTTGATG,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086121 3660661,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007935,,Homo sapiens,,,,,1108133,,UK10K_ALS5086121,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,8,
6,3723939,phiX_for_spiked_buffers,,ACAACGCAAT,,,ACAACGCAAT,,,,,,,1,0,,,PhiX Batch 3 lot 2,,10847,,,,standard,,,,,,,,,,,1255141,,phiX_for_spiked_buffers,,PhiX (Sanger-SNPs),,168,,1,0,0,None,198,Illumina Controls,,,,168,
7,3660662,EGAN00001007929,,CGATGTTT,,Standard,CGATGTTT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086115 3660662,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007929,,Homo sapiens,,,,,1108121,,UK10K_ALS5086115,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,2,
7,3660663,EGAN00001007930,,TTAGGCAT,,Standard,TTAGGCAT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086116 3660663,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007930,,Homo sapiens,,,,,1108123,,UK10K_ALS5086116,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,3,
7,3660664,EGAN00001007931,,TGACCACT,,Standard,TGACCACT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086117 3660664,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007931,,Homo sapiens,,,,,1108125,,UK10K_ALS5086117,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,4,
7,3660665,EGAN00001007932,,ACAGTGGT,,Standard,ACAGTGGT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086118 3660665,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007932,,Homo sapiens,,,,,1108127,,UK10K_ALS5086118,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,5,
7,3660666,EGAN00001007933,,GCCAATGT,,Standard,GCCAATGT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086119 3660666,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007933,,Homo sapiens,,,,,1108129,,UK10K_ALS5086119,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,6,
7,3660667,EGAN00001007934,,CAGATCTG,,Standard,CAGATCTG,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086120 3660667,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007934,,Homo sapiens,,,,,1108131,,UK10K_ALS5086120,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,7,
7,3660661,EGAN00001007935,,ACTTGATG,,Standard,ACTTGATG,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086121 3660661,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007935,,Homo sapiens,,,,,1108133,,UK10K_ALS5086121,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,8,
7,3723939,phiX_for_spiked_buffers,,ACAACGCAAT,,,ACAACGCAAT,,,,,,,1,0,,,PhiX Batch 3 lot 2,,10847,,,,standard,,,,,,,,,,,1255141,,phiX_for_spiked_buffers,,PhiX (Sanger-SNPs),,168,,1,0,0,None,198,Illumina Controls,,,,168,
8,3660662,EGAN00001007929,,CGATGTTT,,Standard,CGATGTTT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086115 3660662,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007929,,Homo sapiens,,,,,1108121,,UK10K_ALS5086115,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,2,
8,3660663,EGAN00001007930,,TTAGGCAT,,Standard,TTAGGCAT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086116 3660663,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007930,,Homo sapiens,,,,,1108123,,UK10K_ALS5086116,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,3,
8,3660664,EGAN00001007931,,TGACCACT,,Standard,TGACCACT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086117 3660664,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007931,,Homo sapiens,,,,,1108125,,UK10K_ALS5086117,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,4,
8,3660665,EGAN00001007932,,ACAGTGGT,,Standard,ACAGTGGT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086118 3660665,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007932,,Homo sapiens,,,,,1108127,,UK10K_ALS5086118,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,5,
8,3660666,EGAN00001007933,,GCCAATGT,,Standard,GCCAATGT,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086119 3660666,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007933,,Homo sapiens,,,,,1108129,,UK10K_ALS5086119,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,6,
8,3660667,EGAN00001007934,,CAGATCTG,,Standard,CAGATCTG,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086120 3660667,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007934,,Homo sapiens,,,,,1108131,,UK10K_ALS5086120,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,7,
8,3660661,EGAN00001007935,,ACTTGATG,,Standard,ACTTGATG,,elg@sanger.ac.uk sm15@sanger.ac.uk,elg@sanger.ac.uk,sm15@sanger.ac.uk,sm15@sanger.ac.uk,,0,0,,,UK10K_ALS5086121 3660661,,9606,S0782,645,UK10K,standard,,,from:350 to:450,EGAN00001007935,,Homo sapiens,,,,,1108133,,UK10K_ALS5086121,,,,168,EGAS00001000090,1,0,0,%09The UK10K project proposes a series of complementary genetic approaches to find new low-frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome-wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein-coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will directly analyse quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.,1782,UK10K_COHORT_ALSPAC,Homo_sapiens (1000Genomes),,UK10K whole genome shotgun sequence%3A ALSPAC cohort,8,
8,3723939,phiX_for_spiked_buffers,,ACAACGCAAT,,,ACAACGCAAT,,,,,,,1,0,,,PhiX Batch 3 lot 2,,10847,,,,standard,,,,,,,,,,,1255141,,phiX_for_spiked_buffers,,PhiX (Sanger-SNPs),,168,,1,0,0,None,198,Illumina Controls,,,,168,

